This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Atrial Fibrillation Diabetes Outcomes 
Heart BMJ
MARCH 26, 2025
2 Therefore, early identification of HF in high-risk populations, particularly post-MI, is essential for improving outcomes. Common predictors include older age, prior hypertension, diabetes and atrial fibrillation. Risk factors for developing HF after MI vary and are influenced by whether the patient has HFrEF or HFpEF.
HeartRhythm
JANUARY 23, 2025
The prevalence of atrial fibrillation (AF) in patients with type 2 diabetes mellitus (T2DM) is reported to be higher than in the general population, ranging from 3.6% to 8.9 % [1].
Heart BMJ
MARCH 26, 2025
Background Heart failure with preserved ejection fraction is a recognised outcome in patients with myocardial infarction, although heart failure with reduced ejection fraction is more common. Patients with pulse pressure ≥68 mm Hg had a 3.83-fold m/s had a 2.10-fold fold higher risk compared with those with lower values.
52 
AMS Cardiology
DECEMBER 14, 2023
Atrial fibrillation often shortened to AFib is an irregular and often rapid heart rhythm that can lead to serious health complications. Control Underlying Medical Conditions – If you have diabetes, high blood pressure or other medical conditions that increase your risk of AFib, it’s crucial to manage them properly.
HeartRhythm
APRIL 30, 2024
Semaglutide is a GLP-1 agonist that modulates metabolism and is shown to have significant cardiovascular outcome benefits. While no dedicated trials of GLP-1 agonists in the atrial fibrillation (AF) population have been reported, diabetes trials demonstrated lower risk of AF occurrence.
HeartRhythm
APRIL 30, 2024
Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are anti-diabetic medications that effectively enhance cardiovascular outcomes in individuals with type 2 diabetes mellitus (T2DM).
40 
Journal of the American Heart Association
FEBRUARY 26, 2025
BackgroundMultimorbidity is common among patients with atrial fibrillation (AF) and is associated with worse outcomes. Multimorbidity was defined as 2 comorbidities (heart failure, hypertension, diabetes, coronary heart disease, kidney dysfunction, moderate or severe mitral valve regurgitation, or obesity).
Journal of Cardiovascular Electrophysiology
FEBRUARY 20, 2024
In patients with atrial fibrillation (AF) ablation and diabetes mellitus (DM), the prevalence of left atrial low-voltage areas (LVAs) increased with increasing glycated hemoglobin A1c (HbA1c) level. In patients with LVAs, freedom from AF recurrence was lower in patients who had DM with HbA1c ≥7% than in those without DM.
Journal of Cardiovascular Electrophysiology
NOVEMBER 5, 2023
Abstract Introduction Influence of early atrial fibrillation (AF) ablation, particularly cryoballoon ablation (CBA), on clinical outcome during long-term follow-up has not been clarified. The primary outcome was recurrence of atrial tachyarrhythmias (ATs) of ≥30-s after a 3-month blanking period.
Journal of Cardiovascular Electrophysiology
JANUARY 9, 2025
ABSTRACT Atrial fibrillation (AF) is the most common cause of arrhythmia-induced cardiomyopathy. Sodium-glucose co-transporter 2 inhibitors (SGLT2i), a novel class of antidiabetic drugs, have shown a promising impact in reducing cardiovascular events in diabetic and nondiabetic heart failure (HF) patients.
Journal of Cardiovascular Electrophysiology
MARCH 3, 2025
ABSTRACT Background Atrial fibrillation (AF) recurrence remains a significant challenge in heart failure with reduced ejection fraction (HFrEF) patients undergoing cryoballoon ablation (CBA). This study assesses the impact of SGLT2i on AF recurrence and clinical outcomes in HFrEF patients undergoing CBA. vs. 39.4%, p =0.036).
Journal of the American Heart Association
DECEMBER 12, 2023
BackgroundThe association between sodium‐glucose cotransporter 2 inhibitors (SGLT2i) and atrial fibrillation (AF) recurrence after catheter ablation among patients with diabetes and AF remains unclear.Methods and ResultsPatients with AF undergoing initial catheter ablation with a history of diabetes from the China AF registry were included.
Circulation
NOVEMBER 11, 2024
Background:Clinical studies on atrial fibrillation (AF) recurrence after catheter ablation in patients diagnosed with patent foramen ovale (PFO) and paroxysmal AF (PAF) are scarce. The constructed nomogram included four clinical variables: age, diabetes mellitus, lipoprotein (a), and right ventricular diameter.
Stroke Journal
JANUARY 30, 2025
Migraine with aura(MwA) is associated with an increased risk of stroke and adverse vascular outcomes compared to those with migraine without aura (MwoA). AI-ECG prediction models developed at our institution can evaluate the probability of atrial fibrillation (AF) and estimate a patients age based on a normal sinus rhythm (NSR) ECG.
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
IntroductionThere is a higher prevalence of diabetes mellitus type 2 in Hispanics as compared to other ethnic groups in the United States. Diabetes is a risk factor for acute ischemic stroke and also a poor predictor of outcome for many interventional surgeries. or greater. vs. 20.5%; p = 0.048) and stenting (28.4%
40 
DAIC
DECEMBER 8, 2023
Getty Images milla1cf Fri, 12/08/2023 - 08:17 December 8, 2023 — The American College of Cardiology (ACC) and the American Heart Association (AHA), along with several other leading medical associations, have issued a new guideline for preventing and optimally managing atrial fibrillation (AFib).
Stroke Journal
JANUARY 30, 2025
Introduction:Intracranial hemorrhage (ICH) is the most severe adverse effect of anticoagulation in atrial fibrillation (AF) patients. Hypertension, diabetes, hyperlipidemia, and chronic kidney disease are well-known cardiovascular risk factors for ICH. Stroke, Volume 56, Issue Suppl_1 , Page A49-A49, February 1, 2025.
Journal of the American Heart Association
DECEMBER 29, 2023
Obesity significantly increases AF risk, both directly and indirectly, through related conditions, like hypertension, diabetes, and heart failure. AF increases the risk of stroke, heart failure, dementia, and hospitalization. However, studies on how obesity affects pharmacologic or interventional AF treatments are limited.
45 
DAIC
FEBRUARY 29, 2024
This year’s theme, “Advancing Cardiovascular Care for All” brings the latest practice-changing breakthroughs, along with top experts debating and discussing outcomes of highly-anticipated clinical trials. 24 from April 6 - 8, 2024 in Atlanta, GA at the Georgia World Congress Center. The Guidelines Sessions at ACC.24
103 
DAIC
JUNE 18, 2024
Smith Center for Outcomes Research in Cardiology and director of the cardiac critical care unit at Beth Israel Deaconess Medical Center in Boston, Mass. The diabetes rate is expected to rise from 16.3% Black children are expected to have the highest overall rates of high blood pressure and diabetes. "We and Susan F.
105 
Open Heart
JUNE 21, 2022
However, the impact of elevated FP as detected by pretranscatheter aortic valve replacement (TAVR) echocardiogram on long-term outcomes after TAVR remains unclear. years and were more likely to be males (62%), diabetic (41% vs 35%, p=0.046), and have a higher prevalence of atrial fibrillation (Afib) (53% vs 39%, p<0.001).
52 
European Journal of Heart Failure
NOVEMBER 26, 2024
Abstract Aims Mineralocorticoid receptor antagonists (MRA) improve outcomes in heart failure with reduced ejection fraction (HFrEF) but are underused. 1.38), a diagnosis of atrial fibrillation (HR 1.24, 95% CI 1.10–1.39), 1.29), diabetes mellitus (HR 1.15, 95% CI 1.04–1.27) 2.27), hyperkalaemia (HR 1.73, 95% CI 1.25–2.40),
ADN Center of Excellence
SEPTEMBER 2, 2024
September is National Atrial Fibrillation (AFib) Awareness Month, a time dedicated to raising awareness about one of the most common yet often misunderstood heart conditions. Understanding Atrial Fibrillation Atrial Fibrillation is characterized by an irregular and often rapid heart rhythm that can lead to poor blood flow.
59 
Circulation
NOVEMBER 11, 2024
The primary outcome was to estimate the prevalence of cardiovascular risk factors in patients with hemophilia compared to the general population. Further research is to identify potential ex-specific risk factors that predispose to worse cardiovascular outcomes among patients with hemophilia.
40 Coronary Artery Disease Journal
MAY 13, 2024
Objective To investigate the impact of prior coronary artery bypass grafting (CABG) and coronary lesion complexity on transcatheter aortic valve replacement (TAVR) outcomes for aortic stenosis. 23), which was not associated with better/worse clinical outcomes in patients with prior CABG.
Stroke Journal
JANUARY 30, 2025
Propensity score-matched analysis (PSM) (1:1) was performed with matching for age, gender, race, BMI, hypertension, diabetes mellitus, chronic kidney disease, hemoglobin level, low-density lipid (LDL) level, left ventricular ejection fraction, and various drugs including ACEi, ARBi, ARNI, beta-blockers, and diuretics. years, with 49.27% men.
40 Stroke Journal
JANUARY 30, 2025
Background:The STRACK project aims to improve post-stroke patient management and the transition from acute to primary care thanks to improvements in patient pathways and monitoring cardiovascular risk factors: heart failure, diabetes, atrial fibrillation, dyslipidemia and hypertension.
40 Coronary Artery Disease Journal
JANUARY 11, 2024
Previous studies showed considerable risks of outcomes in this group. In this study, we aimed to investigate the long-term outcomes in very young patients with MINOCA. They had significantly lower rates of diabetes and hypertension and higher rates of male gender and smoking compared to the older group.
ADN Center of Excellence
SEPTEMBER 2, 2024
September is National Atrial Fibrillation (AFib) Awareness Month, a time dedicated to raising awareness about one of the most common yet often misunderstood heart conditions. Understanding Atrial Fibrillation Atrial Fibrillation is characterized by an irregular and often rapid heart rhythm that can lead to poor blood flow.
52 Heart BMJ
MAY 10, 2024
Arrhythmias, and in particular atrial fibrillation (AF), are one of the greatest healthcare challenges of our time. Arrhythmia prediction models have long relied on conventional risk factors such as age, diabetes, hypertension, and history of myocardial infarction and heart failure.
40 
Stroke Journal
FEBRUARY 1, 2024
Introduction:Clinical characteristics of patients with in-hospital onset stroke (IHOS) compared to those with out-of-hospital onset stroke are reported to be late detection of stroke onset, less use of rt-PA, presence of atrial fibrillation, and poor outcome.
40 
Open Heart
APRIL 5, 2022
Patients with SADMR were older, less females and had more diabetes, but similar rates of atrial fibrillation. They underwent fewer MV interventions, although these were associated with better outcomes (log-rank p<0.001). MR severity and ejection fraction were similar between both groups. vs 15.5%, p<0.001).
Stroke Journal
FEBRUARY 1, 2024
Studies have reported racial disparities in young stroke patients and less desired outcomes of minorities. Socioeconomic status, risk factors, stroke etiology, acute interventions and short-term outcomes were accessed. Compared to White, black and Hispanic had higher rate of Diabetes, Hypertension and prior stroke (p<0.001).
40 Journal of Cardiothoracic Surgery
FEBRUARY 2, 2024
A retrospective analysis was conducted on clinical, operative, and outcome data from 1070 patients (mean age: 59 ± 9.8& The outcome variable was prolonged length of stay LOS in the CICU stay (> 3 nights after CABG). This study aimed to evaluate these risk factors.
40 
Physiologically Speaking
JULY 26, 2024
We talk about the ketogenic diet as a metabolic therapy for type 1 diabetes. Dozens if not hundreds of (albeit observational) studies have linked a short sleep duration to a number of health conditions including type 2 diabetes and cardiovascular disease. Welcome to the Physiology Friday newsletter.
Stroke Journal
FEBRUARY 1, 2024
We compared hemorrhagic change after MT, outcome at discharge and clinical characteristics between two groups. Patients outcomes were classified into two group; good outcome as modified Rankin Scale (mRS) 0-2 and poor outcome as mRS 5-6, respectively. The occurrence of hemorrhagic change was assessed on CT after MT.
40 Stroke Journal
JANUARY 30, 2025
Ensuring a follow-up neurology appointment within two weeks is vital to managing stroke risk factors like hypertension, diabetes, and atrial fibrillation. Introduction:Effective care transition for ischemic or hemorrhagic stroke patients post-hospital discharge is critical.
40 
European Journal of Heart Failure
SEPTEMBER 15, 2023
A prior history of the following comorbidities was considered: episodic or persistent atrial fibrillation ( n = 920), coronary artery disease ( n = 3732), diabetes ( n = 2171), and hypertension ( n = 3353). Outcomes were evaluated within each comorbidity group using a Bayesian hierarchical Weibull survival regression model.
Stroke Journal
JANUARY 30, 2025
Patients were also provided with the stroke nurses direct contact information to help navigate the healthcare system.
40 
Stroke Journal
FEBRUARY 1, 2024
The primary outcome was incident ischemic stroke. Participants with LVI were more likely to have diabetes, tobacco use, and atrial fibrillation (24% versus 14%, p<0.001). with LVI, n=2,282 or 88.3% without LVI). Participants with LVI were significantly older, male, Black, had higher BMI, and lower HDL.
Stroke Journal
FEBRUARY 1, 2024
Large vessel occlusion (LVO) is found in 10% of MSS cases and predicts poor neurological outcomes. Descriptive statistics were applied to demographic, clinical, radiographic, and neurological outcomes data, including early neurological deterioration (END) (NIHSS gain 3+).Results:Ninety years old, with 58.8% black, and 16.2%
40 
Stroke Journal
FEBRUARY 1, 2024
Difference in 90 day mRS and baseline mRS (delta mRS) was calculated as primary outcome measure. Two groups of patients were created; patients without existing disability (modified Rankin Score [mRS] 0-1) and those with existing disability (mRS≥2). Demographics and comorbidities were compared.
40 
DAIC
DECEMBER 19, 2023
OSA is commonly seen in patients with arrhythmias like atrial fibrillation (AFib) and due to the variable unpredictable nature of sleep apnea symptoms, it is often untreated, leading to adverse outcomes. Western Regional Director of Cardiac Electrophysiology, Northwell Health , NY. billion (2).
Dr. Smith's ECG Blog
NOVEMBER 4, 2022
Case submitted and written by Mazen El-Baba MD, with edits from Jesse McLaren and edits/comments by Smith and Grauer A 90-year old with a past medical history of atrial fibrillation, type-2 diabetes, hypertension, dyslipidemia, presented with acute onset chest/epigastric pain, nausea, and vomiting.
52
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content